BIBN 4096 BS Clinical Proof of Concept Study Group: Calcitonin gene-related peptide (CGRP) receptor antagonist BIBN 4096 BS is effective in the treatment of migraine attacks - Olesen, J (N Engl J Med, 2004)
et al.